(84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO
PL PT RO SE SI SK TR |
(30) |
Priority: |
27.05.2008 US 128939 P
|
(43) |
Date of publication of application: |
|
17.09.2014 Bulletin 2014/38 |
(62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
09754139.5 / 2297106 |
(73) |
Proprietors: |
|
- AstraZeneca AB
151 85 Södertälje (SE) Designated Contracting States: AT BE BG CH CY CZ DK EE ES FI GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
- Galderma S.A.
6330 Cham (CH) Designated Contracting States: DE FR GB
|
|
(72) |
Inventors: |
|
- Andrews, Glen
Macclesfield, Cheshire SK10 4TG (GB)
- Cox, Rhona, Jane
SE 431 83 Mölndal (SE)
- De Savi, Christopher
Waltham, Massachusetts 02451 (US)
- Meghani Premji
Macclesfield, Cheshire SK10 4TG (GB)
- Sanganee, Hitesh Jayantilal
Macclesfield, Cheshire SK10 4TG (GB)
- Warner, Daniel, Jon
Waltham, Massachusetts 02451 (US)
|
(74) |
Representative: Lowry, Rachel Maria |
|
AstraZeneca UK Limited,
Intellectual Property,
Mereside,
Alderley Park Macclesfield, Cheshire SK10 4TG Macclesfield, Cheshire SK10 4TG (GB) |
(56) |
References cited: :
US-A1- 2003 220 366 US-A1- 2005 020 639
|
US-A1- 2005 020 626 US-A1- 2005 032 838
|
|
|
|
|
|
|